Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cancers; study is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Diseases
• Myelodysplastic Syndromes
• Plasma Cell Neoplasm

Drugs mentioned

• Laboratory-treated donor bone marrow

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Graft Versus Host Disease, Leukemia | Phase 3 | Status: COMPLETED